Organogenesis Holdings (ORGO) Stock Statistics & Valuation Metrics

Organogenesis Holdings has a market cap or net worth of $384.37M. The enterprise value is ―.

Organogenesis Holdings has 126,853,540 shares outstanding. The number of shares has decreased by -2.65% in one year.

Organogenesis Holdings’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.09%.

The current PE Ratio of Organogenesis Holdings is 489.38. Organogenesis Holdings’s PEG ratio is 3.75.

In the last 12 months, Organogenesis Holdings had revenue of 482.04M and earned 861.00K in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was 14.21M and capital expenditures -10.03M, giving a free cash flow of 4.18M billion.

Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Organogenesis Holdings upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

Organogenesis Holdings as a current ratio of 3.69, with Debt / Equity ratio of 16.47%

In the past 12 months, Organogenesis Holdings has paid -3.67M in taxes.

Organogenesis Holdings EV to EBITDA ratio is -256.50, with an EV/FCF ratio of 78.81.

Organogenesis Holdings has $135.57M in cash and marketable securities with $43.31M in debt, giving a net cash position of -$92.26M billion.

Gross margin is 74.32%, with operating margin of -0.27%, and net profit margin of 0.18%.

The average price target for Organogenesis Holdings is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy